Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Novel biomarkers of cardiometabolic risk are associated with plasma glucose within non-diabetic range. The Brazilian Longitudinal Study of Adult Health - ELSA-Brasil

Texto completo
Autor(es):
Almeida-Pititto, Bianca [1] ; Ribeiro-Filho, Fernando F. [2] ; Lotufo, Paulo A. [3] ; Bensenor, Isabela M. [3] ; Ferreira, Sandra R. G. [1]
Número total de Autores: 5
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Sch Publ Hlth, BR-05508000 Sao Paulo, SP - Brazil
[2] Fed Univ Para, Dept Med, Belem, PA - Brazil
[3] Univ Sao Paulo, Univ Hosp, Ctr Clin & Epidemiol Res, BR-05508000 Sao Paulo, SP - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: Diabetes Research and Clinical Practice; v. 109, n. 1, p. 110-116, JUL 2015.
Citações Web of Science: 5
Resumo

Abnormal glucose metabolism preceding overt diabetes is associated with increased cardiovascular risk. Whether novel biomarkers are useful to identify this condition is unclear. The objective was to investigate associations of biomarkers of atherogenesis with plasma glucose within non-diabetic range. 998 participants (35-54 years) of the Brazilian Longitudinal Study of Adult Health without diabetes or cardiovascular disease were classified as normal glucose tolerance (NGT), impaired fasting glycemia (IFG) and impaired glucose tolerance (IGT). Traditional risk factors and markers of atherogenesis were evaluated among groups and across plasma glucose concentrations. IFG and IGT had worse profile considering traditional cardiovascular risk factors than the NGT group, although these values were within the reference range. NGT, IFG and IGT groups differed (medians and interquartile intervals) regarding transforming growth factor-beta 1 {[}12.2 (6.4-22.3), 16.8 (8.4-26.5), and 15.5 (8.0-26.1) pg/mL, p < 0.05], C-reactive protein {[}1.1 (0.6-2.9), 1.2 (0.6-2.7), and 1.4 (0.8-3.7) ng/mL, p < 0.001] and monocyte chemoattractant protein-1 {[}35.9 (21.2-57.8), 32.2 (18.7-55.8), and 34.1 (18.6-52.4) pg/mL, p < 0.05]. TGF-beta 1 and E-selectin concentrations increased while MCP-1 decreased across quartiles of fasting plasma glucose. C-reactive protein increased with increments in 2-h plasma glucose. In linear regression, TGF-beta 1 was independently associated with fasting plasma glucose, and C-reactive protein with 2-h plasma glucose after adjustments. In conclusion, association of TGF-beta 1, E-selectin, C-reactive protein and MCP-1 with slight elevations in glycemia may be anticipating alterations in traditional cardiovascular risk factors. Independent association of TGF-beta 1 with plasma glucose suggests that this may be useful to identifying atherogenic process, deserving further investigation on the prediction of cardiovascular outcomes. (C) 2015 Elsevier Ireland Ltd. All rights reserved. (AU)

Processo FAPESP: 10/00074-6 - Fatores não-tradicionais de risco cardiometabólico no espectro da síndrome metabólica no ELSA - São Paulo
Beneficiário:Bianca de Almeida Pititto
Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado